ArticleJournal of asthma and allergy2023

Real-World Safety and Effectiveness of Omalizumab in Moderate to Severe Allergic Asthma Patients in China: A Post-Authorization Study.

Nan Su et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.